TET2 and acute myeloid leukemia: Although there were still controversies over the clinical significance of TET2 mutations according to different conclusions from a variety of studies, we confirmed the unfavorable impacts of TET2 mutations on response to therapy and prognosis in AML stratified by age or cytogenetics.